1.
Public Health England - Diabetes prevention programmes: evidence review. Published online 2015. https://www.gov.uk/government/publications/diabetes-prevention-programmes-evidence-review
2.
American Diabetes Association - Standards of Medical Care in Diabetes - 2017 Summary of Revisions. Diabetes Care. 2017;40(Supplement 1):S4-S5. doi:10.2337/dc17-S003
3.
NICE - Type 2 diabetes: prevention in people at high risk | Guidance and guidelines. https://www.nice.org.uk/guidance/ph38
4.
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine. 2002;346(6):393-403. doi:10.1056/NEJMoa012512
5.
Gillies CL, Abrams KR, Lambert PC, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007;334(7588):299-299. doi:10.1136/bmj.39063.689375.55
6.
Lindstrom J, Louheranta A, Mannelin M, et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26(12):3230-3236. doi:10.2337/diacare.26.12.3230
7.
Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289-297. doi:10.1007/s00125-005-0097-z
8.
Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. New England Journal of Medicine. 2001;344(18):1343-1350. doi:10.1056/NEJM200105033441801
9.
Matti Uusitupa. Ten-Year Mortality and Cardiovascular Morbidity in the Finnish Diabetes Prevention Study—Secondary Analysis of the Randomized Trial. PLoS ONE. 2009;4(5). doi:doi:  10.1371/journal.pone.0005656
10.
Brown J, Alwan NA, West J, et al. Lifestyle interventions for the treatment of women with gestational diabetes. In: Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd; 1996. doi:10.1002/14651858.CD011970.pub2
11.
Carlsson LMS, Peltonen M, Ahlin S, et al. Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects. New England Journal of Medicine. 2012;367(8):695-704. doi:10.1056/NEJMoa1112082
12.
Tseng E, Yeh HC, Maruthur NM. Metformin Use in Prediabetes Among U.S. Adults, 2005?2012. Diabetes Care. 2017;40(7):887-893. doi:10.2337/dc16-1509
13.
Luchsinger JA, Ma Y, Christophi CA, et al. Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2017;40(7):958-965. doi:10.2337/dc16-2376
14.
Breeze PR, Thomas C, Squires H, et al. The impact of Type 2 diabetes prevention programmes based on risk-identification and lifestyle intervention intensity strategies: a cost-effectiveness analysis. Diabetic Medicine. 2017;34(5):632-640. doi:10.1111/dme.13314
15.
Fogelholm M, Larsen T, Westerterp-Plantenga M, et al. PREVIEW: Prevention of Diabetes through Lifestyle Intervention and Population Studies in Europe and around the World. Design, Methods, and Baseline Participant Description of an Adult Cohort Enrolled into a Three-Year Randomised Clinical Trial. Nutrients. 2017;9(6). doi:10.3390/nu9060632
16.
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine. 2002;346(6):393-403. doi:10.1056/NEJMoa012512
17.
Gray LJ, Yates T, Troughton J, Khunti K, Davies MJ. Engagement, Retention, and Progression to Type 2 Diabetes: A Retrospective Analysis of the Cluster-Randomised ‘Let’s Prevent Diabetes’ Trial. PLOS Medicine. 2016;13(7). doi:10.1371/journal.pmed.1002078
18.
A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let’s Prevent Diabetes cluster randomised controlled trial- ClinicalKey. https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0091743515003850
19.
Barry E, Roberts S, Oke J, Vijayaraghavan S, Normansell R, Greenhalgh T. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ. Published online 4 January 2017. doi:10.1136/bmj.i6538
20.
Webb DR, Gray LJ, Khunti K, et al. Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. Diabetologia. 2011;54(9):2237-2246. doi:10.1007/s00125-011-2189-2
21.
Screening for type 2 diabetes: literature review and economic modelling. Clinical Governance: An International Journal. 2007;12(4). doi:10.1108/cgij.2007.24812dae.003
22.
Gray LJ, Taub NA, Khunti K, et al. The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabetic Medicine. 2010;27(8):887-895. doi:10.1111/j.1464-5491.2010.03037.x
23.
Gray LJ, Davies MJ, Hiles S, et al. Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia. 2012;55(4):959-966. doi:10.1007/s00125-011-2432-x
24.
Rajul Parikh,Annie Mathai,Shefali Parikh,G. Chandra Sekhar,Ravi Thomas. Understanding and using sensitivity, specificity and predictive values. Indian Journal of Ophthalmology. http://go.galegroup.com.ezproxy4.lib.le.ac.uk/ps/retrieve.do?tabID=T002&resultListType=RESULT_LIST&searchResultsType=SingleTab&searchType=AdvancedSearchForm&currentPosition=3&docId=GALE%7CA173264871&docType=Article&sort=Relevance&contentSegment=&prodId=EAIM&contentSet=GALE%7CA173264871&searchId=R1&userGroupName=leicester&inPS=true
25.
Helen C Eborall. Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ : British Medical Journal. 2007;335(7618). doi:doi:  10.1136/bmj.39303.723449.55
26.
Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review. Diabetes Care. 2010;33(8):1872-1894. doi:10.2337/dc10-0843
27.
Clinical applicability and cost-effectiveness of DIABSCORE in screening for type 2 diabetes in primary care- ClinicalKey. https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0168822717301031
28.
Hamman RF, Wing RR, Edelstein SL, et al. Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes. Diabetes Care. 2006;29(9):2102-2107. doi:10.2337/dc06-0560
29.
Joiner KL, Nam S, Whittemore R. Lifestyle interventions based on the diabetes prevention program delivered via eHealth: A systematic review and meta-analysis. Preventive Medicine. 2017;100:194-207. doi:10.1016/j.ypmed.2017.04.033
30.
Georgios S Papaetis. Incretin-based therapies in prediabetes: Current evidence and future perspectives. World Journal of Diabetes. 2014;5(6). doi:doi:  10.4239/wjd.v5.i6.817
31.
Obesity: identification, assessment and management | Guidance and guidelines | NICE. https://www.nice.org.uk/guidance/cg189
32.
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. New England Journal of Medicine. Published online 12 June 2017. doi:10.1056/NEJMoa1614362
33.
Gregg EW, Shaw JE. Global Health Effects of Overweight and Obesity. New England Journal of Medicine. Published online 12 June 2017. doi:10.1056/NEJMe1706095
34.
A Systems Science Approach to the Obesity Epidemic and Prevention of Diabetes. Published online 20AD. https://www.youtube.com/watch?v=HrrD-Z0B7dY&feature=youtu.be&t=55s%20A%20Systems%20Science%20Approach%20to%20the%20Obesity%20Epidemic%20and%20Prevention%20of%20Diabetes.
35.
Carlsson LMS, Peltonen M, Ahlin S, et al. Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects. New England Journal of Medicine. 2012;367(8):695-704. doi:10.1056/NEJMoa1112082
36.
Linda Penn. Importance of Weight Loss Maintenance and Risk Prediction in the Prevention of Type 2 Diabetes: Analysis of European Diabetes Prevention Study RCT. PLoS ONE. 2013;8(2). doi:doi:  10.1371/journal.pone.0057143
37.
Aguiar EJ, Morgan PJ, Collins CE, Plotnikoff RC, Young MD, Callister R. Efficacy of the Type 2 Diabetes Prevention Using LifeStyle Education Program RCT. American Journal of Preventive Medicine. 2016;50(3):353-364. doi:10.1016/j.amepre.2015.08.020
38.
Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial- ClinicalKey. https://www.clinicalkey.com/#!/content/journal/1-s2.0-S2213858713702043
39.
Linda Penn. Importance of Weight Loss Maintenance and Risk Prediction in the Prevention of Type 2 Diabetes: Analysis of European Diabetes Prevention Study RCT. PLoS ONE. 2013;8(2). doi:doi:  10.1371/journal.pone.0057143
40.
Long GH, Johansson I, Rolandsson O, et al. Healthy behaviours and 10-year incidence of diabetes: A population cohort study. Preventive Medicine. 2015;71:121-127. doi:10.1016/j.ypmed.2014.12.013
41.
Nutrition Recommendations and Interventions for Diabetes: A position statement of the American Diabetes Association. Diabetes Care. 2008;31(Supplement 1):S61-S78. doi:10.2337/dc08-S061
42.
Carter P, Khunti K, Davies MJ. Dietary Recommendations for the Prevention of Type 2 diabetes: What Are They Based on? Journal of Nutrition and Metabolism. 2012;2012:1-6. doi:10.1155/2012/847202
43.
Pan XR, Li GW, Hu YH, et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537-544. doi:10.2337/diacare.20.4.537
44.
How to prevent type 2 diabetes in women with previous gestational diabetes? A systematic review of behavioural interventions- ClinicalKey. https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S1751991817300785?returnurl=null&referrer=null
45.
Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, Hu FB. Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes: A meta-analysis. Diabetes Care. 2010;33(11):2477-2483. doi:10.2337/dc10-1079
46.
Schulze MB. Sugar-Sweetened Beverages, Weight Gain, and Incidence of Type 2 Diabetes in Young and Middle-Aged Women. JAMA. 2004;292(8). doi:10.1001/jama.292.8.927
47.
Correction. Circulation. 2007;116(23):e557-e557. doi:10.1161/CIRCULATIONAHA.107.187928
48.
Malik VS, Pan A, Willett WC, Hu FB. Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. American Journal of Clinical Nutrition. 2013;98(4):1084-1102. doi:10.3945/ajcn.113.058362
49.
Deborah F Tate. Replacing caloric beverages with water or diet beverages for weight loss in adults: main results of the Choose Healthy Options Consciously Everyday (CHOICE) randomized clinical trial. The American Journal of Clinical Nutrition. 2012;95(3). doi:doi:  10.3945/ajcn.111.026278
50.
Pan A, Sun Q, Bernstein AM, et al. Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. American Journal of Clinical Nutrition. 2011;94(4):1088-1096. doi:10.3945/ajcn.111.018978
51.
Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. The Lancet. 2014;383(9933):1999-2007. doi:10.1016/S0140-6736(14)60613-9
52.
Type 2 diabetes: prevention in people at high risk | Guidance and guidelines | NICE. https://www.nice.org.uk/guidance/ph38/documents/preventing-type-2-diabetes-risk-identification-and-interventions-for-individuals-at-high-risk-draft-guidance-consultation
53.
Emily A Hu. White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review. The BMJ. 2012;344. doi:doi:  10.1136/bmj.e1454
54.
Dagfinn Aune. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies. The BMJ. 2016;353. doi:doi:  10.1136/bmj.i2716
55.
Dyson PA, Kelly T, Deakin T, et al. Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabetic Medicine. 2011;28(11):1282-1288. doi:10.1111/j.1464-5491.2011.03371.x
56.
Schwingshackl L, Hoffmann G, Lampousi AM, et al. Food groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. European Journal of Epidemiology. 2017;32(5):363-375. doi:10.1007/s10654-017-0246-y
57.
Mann J, Morenga LT, McLean R, et al. Dietary guidelines on trial: the charges are not evidence based. The Lancet. 2016;388(10047):851-853. doi:10.1016/S0140-6736(16)31278-8
58.
Dhingra R, Sullivan L, Jacques PF, et al. Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults in the Community. Circulation. 2007;116(5):480-488. doi:10.1161/CIRCULATIONAHA.107.689935
59.
Wu Y, Zhang D, Jiang X, Jiang W. Fruit and vegetable consumption and risk of type 2 diabetes mellitus: A dose-response meta-analysis of prospective cohort studies. Nutrition, Metabolism and Cardiovascular Diseases. 2015;25(2):140-147. doi:10.1016/j.numecd.2014.10.004
60.
Diff erences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. http://ac.els-cdn.com/S2213858714701469/1-s2.0-S2213858714701469-main.pdf?_tid=41970bbc-7e93-11e7-a8e5-00000aab0f01&acdnat=1502455838_1e4678aef6e5b79c43c42f6b68f370f1
61.
Aune D, Norat T, Romundstad P, Vatten LJ. Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose–response meta-analysis of cohort studies. European Journal of Epidemiology. 2013;28(11):845-858. doi:10.1007/s10654-013-9852-5
62.
Colberg SR, Sigal RJ, Fernhall B, et al. Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 2010;33(12):2692-2696. doi:10.2337/dc10-1548
63.
Yates T, Wilmot EG, Khunti K, Biddle S, Gorely T, Davies MJ. Stand up for your health: Is it time to rethink the physical activity paradigm? Diabetes Research and Clinical Practice. 2011;93(2):292-294. doi:10.1016/j.diabres.2011.03.023
64.
Steven N Blair. Physical inactivity: the biggest public health problem of the 21st century. British Journal of Sports Medicine. 2009;43:1-2. http://bjsm.bmj.com/content/43/1/1.full
65.
Laaksonen DE, Lindstrom J, Lakka TA, et al. Physical Activity in the Prevention of Type 2 Diabetes: The Finnish Diabetes Prevention Study. Diabetes. 2005;54(1):158-165. doi:10.2337/diabetes.54.1.158
66.
Thomas Yates. Walking away from type 2 diabetes: trial protocol of a cluster randomised controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetes. BMC Family Practice. 2012;13. doi:doi:  10.1186/1471-2296-13-46
67.
Colberg SR, Sigal RJ, Yardley JE, et al. Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065-2079. doi:10.2337/dc16-1728
68.
Stefan N, Staiger H, Wagner R, et al. A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes. Diabetologia. 2015;58(12):2877-2884. doi:10.1007/s00125-015-3760-z
69.
Less Sitting, More Physical Activity, or Higher Fitness?- ClinicalKey. https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/playContent/1-s2.0-S0025619615006308?returnurl=null&referrer=null
70.
Sedentary Behaviors and Subsequent Health Outcomes in Adults- ClinicalKey. https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/journal/1-s2.0-S0749379711003126
71.
LaMonte MJ. Physical activity and diabetes prevention. Journal of Applied Physiology. 2005;99(3):1205-1213. doi:10.1152/japplphysiol.00193.2005
72.
Church TS, Blair SN, Cocreham S, et al. Effects of Aerobic and Resistance Training on Hemoglobin A                              Levels in Patients With Type 2 Diabetes. JAMA. 2010;304(20). doi:10.1001/jama.2010.1710
73.
Orozco LJ, Buchleitner AM, Gimenez-Perez G, Roqué i Figuls M, Richter B, Mauricio D. Exercise or exercise and diet for preventing type 2 diabetes mellitus. In: Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd; 1996. doi:10.1002/14651858.CD003054.pub3
74.
Sedentary Behaviors and Subsequent Health Outcomes in Adults- ClinicalKey. https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/journal/1-s2.0-S0749379711003126
75.
Gopalan A, Lorincz IS, Wirtalla C, Marcus SC, Long JA. Awareness of Prediabetes and Engagement in Diabetes Risk?Reducing Behaviors. American Journal of Preventive Medicine. 2015;49(4):512-519. doi:10.1016/j.amepre.2015.03.007
76.
Absetz P, Oldenburg B, Hankonen N, et al. Type 2 Diabetes Prevention in the Real World: Three-year results of the GOAL Lifestyle Implementation Trial. Diabetes Care. 2009;32(8):1418-1420. doi:10.2337/dc09-0039
77.
Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the Community. American Journal of Preventive Medicine. 2008;35(4):357-363. doi:10.1016/j.amepre.2008.06.035
78.
Sweeting AN, Ross GP, Hyett J, et al. Gestational Diabetes Mellitus in Early Pregnancy: Evidence for Poor Pregnancy Outcomes Despite Treatment. Diabetes Care. 2016;39(1):75-81. doi:10.2337/dc15-0433
79.
Koivusalo SB, Rönö K, Klemetti MM, et al. Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL). Diabetes Care. 2016;39(1):24-30. doi:10.2337/dc15-0511
80.
Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care. Diabetes Care. 2007;30(3):753-759. doi:10.2337/dc07-9920
81.
Vita P, Cardona-Morrell M, Bauman A, et al. Type 2 diabetes prevention in the community: 12-Month outcomes from the Sydney Diabetes Prevention Program. Diabetes Research and Clinical Practice. 2016;112:13-19. doi:10.1016/j.diabres.2015.11.010
82.
Breeze PR, Thomas C, Squires H, et al. Cost-effectiveness of population-based, community, workplace and individual policies for diabetes prevention in the UK. Diabetic Medicine. 2017;34(8):1136-1144. doi:10.1111/dme.13349
83.
The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention: An intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012;35(4):723-730. doi:10.2337/dc11-1468
84.
Bailey, Stephen. Academic Writing : A Handbook for International Students. 5th ed. https://ebookcentral.proquest.com/lib/leicester/detail.action?docID=5178437
85.
Creme P, Lea MR. Writing At University: A Guide For Students. 3rd ed. McGraw-Hill Education; 2008. https://ebookcentral.proquest.com/lib/leicester/detail.action?pq-origsite=primo&docID=345134